Home
Conditions
Esophageal Adenocarcinoma

Clinical trial condition

Esophageal Adenocarcinoma

Explore clinical trials studying Esophageal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

93 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Adenocarcinoma trial results

Recruiting

Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)

NCT05177133

Conditions: Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +4 more
Locations: Academic Medical Center, Medical Oncology Amsterdam, Netherlands

Amsterdam UMC, location VUmc Amsterdam, Netherlands

Catharina ziekenhuis Eindhoven, Netherlands

Medisch Centrum Leeuwarden Leeuwarden, Netherlands

View Trial Details

Recruiting

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

NCT00574327

Conditions: Adenocarcinoma Of Esophagus, Barrett Esophagus, Barrett's Esophagus, +10 more
Locations: Department of Veterans Affairs Medical Center Kansas City, Missouri, United States

View Trial Details

Recruiting

A Multicenter Prospective Cohort Study Comparing Random Biopsies Versus Wide-Area Transepithelial Brush-Sampling (WATS) for Surveillance of Barrett's Esophagus, the WATS-EURO2 Study

NCT05642338

Conditions: Adenocarcinoma Of Esophagus, Barrett Esophagus, Diagnosis, +9 more
Locations: Amsterdam University Medical Centre, loc. VUmc Amsterdam, North Holland, Netherlands

View Trial Details

Recruiting

TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer

NCT05188313

Conditions: Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Academic Medical Center Amsterdam, Netherlands

View Trial Details

Recruiting

RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).

NCT04306458

Conditions: Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma
Locations: University Medical Center Mainz Mainz, Germany

View Trial Details

Enrolling by Invitation

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma

NCT07212491

Conditions: Adenocarcinoma Of Esophagus, Barrett Esophagus, Digestive System Diseases, +5 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Not Yet Recruiting

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

NCT07206589

Conditions: Adenocarcinoma Of Esophagus, Barrett Esophagus, Digestive System Diseases, +5 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

Mayo Clinic Health System-Eau Claire Clinic Eau Claire, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

NCT07059611

Conditions: Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +1 more
Locations: Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Not Yet Recruiting

Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma

NCT07603375

Conditions: Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Not Yet Recruiting

Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy

NCT07164690

Conditions: Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Radiotherapy
Locations: Not specified

View Trial Details

Esophageal Adenocarcinoma

Esophageal Adenocarcinoma trial results

Related conditions